531739 — Gennex Laboratories Share Price
0.000.00%
Last trade - 00:00- IN₹3.14bn
- IN₹2.97bn
- IN₹867.14m
- 38
- 41
- 16
- 19
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 1.74 | ||
| Price to Tang. Book | 1.77 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 2.39 | ||
| EV to EBITDA | 15.65 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 8.22% | ||
| Return on Equity | 13.73% | ||
| Operating Margin | 12.71% | ||
Financial Summary
| Year End 31st Mar | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | IN₹m | 556.17 | 596.49 | 612.14 | 656.03 | 867.14 | n/a | n/a | 9.22% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | -19.97 | +143.88 | -9.48 | +13.86 | +109.34 | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Gennex Laboratories Limited is an India-based active pharmaceutical ingredient manufacturing company. The Company is engaged in the business of manufacturing of bulk drugs and intermediaries. It offers products in various therapeutic categories, including expectorant (mucolyte), relaxant (skeletal muscle relaxant), antihistamines, urinary tract analgesic, antifungals called triazoles, tricyclic antidepressant, acting muscle relaxants, muscle relaxant, selective serotonin reuptake inhibitors (SSRIS), and xanthine oxidase inhibitors. Its products include Guaifenesin, Methocarbamol, Fexofenadine Hcl, Phenazopyridine Hcl, Fluconazole, Melitracen Hcl, Mephenesin, Chlorphenesin, Sertraline Hcl and Allopurinol. The Company has manufacturing facilities in India which cater to both domestic and international markets. Its international markets include Bangladesh, Bolivia, China, Colombia, Costa Rica, Cuba, Germany, Indonesia, Iran, Iraq, Israel, Jordan, Kenya, South Korea, Malaysia and Mexico.
Directors
- K. Bhaswanth COO
- Rajesh Vankadara, CCO
- Arihant Baid MDR
- Tiruvarur Gopalakrishnan EDR
- U. Bhandari NID (60)
- Y. Ravinder Reddy NID (47)
- Last Annual
- March 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- March 29th, 1990
- Public Since
- February 9th, 1996
- Sector
- Pharmaceuticals
- Industry
- Healthcare
- Exchange
- Bombay Stock Exchange
- Shares in Issue
- 227,447,674
- Address
- Akash Ganga 3rd Floor, HYDERABAD, 500073
- Web
- https://www.gennexlab.com/
- Phone
- +91 4067334400
- Auditors
- RPugalia & company
Upcoming Events for 531739
Q1 2026 Gennex Laboratories Ltd Earnings Release
Similar to 531739
Aayush Wellness
Bombay Stock Exchange
Achyut Healthcare
Bombay Stock Exchange
Adline Chem Lab
Bombay Stock Exchange
MPS Pharmaa
Bombay Stock Exchange
Albert David
Bombay Stock Exchange
FAQ
What is the Gennex Laboratories share price?
As of Today at 20:47 UTC, shares in Gennex Laboratories are trading at IN₹13.79. This share price information is delayed by 15 minutes.
How has the Gennex Laboratories share price performed this year?
Shares in Gennex Laboratories last closed at IN₹13.79 and the price had moved by -14.72% over the past 365 days. In terms of relative price strength the Gennex Laboratories share price has underperformed the S&P BSE 100 Index by -20.99% over the past year.
What are the analyst and broker recommendations for Gennex Laboratories?
There is no consensus recommendation for this security.
Find out moreWhat is the Gennex Laboratories dividend yield?
Gennex Laboratories does not currently pay a dividend.
Does Gennex Laboratories pay a dividend?
Gennex Laboratories does not currently pay a dividend.
When does Gennex Laboratories next pay dividends?
Gennex Laboratories does not currently pay a dividend.
How do I buy Gennex Laboratories shares?
To buy shares in Gennex Laboratories you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Gennex Laboratories?
As of the previous close price of IN₹13.79, shares in Gennex Laboratories had a market capitalisation of IN₹3.14bn.
Where are Gennex Laboratories shares listed?
Here are the trading details for Gennex Laboratories:
- Country of listing: India
- Exchange: BSE
- Ticker Symbol: 531739
What kind of share is Gennex Laboratories?
Based on an overall assessment of its quality, value and momentum Gennex Laboratories is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Gennex Laboratories share price forecast for 2025?
We could not find analyst target price data for this security.
Find out moreWhat is the trend in the Gennex Laboratories share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Gennex Laboratories. Over the past six months, its share price has underperformed the S&P BSE 100 Index by -35.28%.
As of the last closing price of IN₹13.79, shares in Gennex Laboratories were trading -19.05% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Gennex Laboratories PE Ratio?
The Gennex Laboratories PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at IN₹13.79.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Gennex Laboratories?
Gennex Laboratories' management team is headed by:
- K. Bhaswanth - COO
- Rajesh Vankadara, - CCO
- Arihant Baid - MDR
- Tiruvarur Gopalakrishnan - EDR
- U. Bhandari - NID
- Y. Ravinder Reddy - NID